Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids
- PMID: 9825265
- DOI: 10.1007/s004170050174
Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids
Abstract
Background: The purpose of the study is to demonstrate the development of subretinal fibrotic scar formation in central serous chorioretinopathy (CSCR) that developed during systemic corticosteroid treatment.
Methods: The clinical and photographic records of a patient in whom an unusual manifestation of severe central serous chorioretinopathy developed during systemic corticosteroid treatment were reviewed.
Results: A 34-year-old man received high dosages of corticosteroids for several years because of severe asthma. There was no previous history of idiopathic CSCR. He developed three successive attacks of CSCR. On the third occasion, an unusual variant of severe CSCR was observed which presented as a bullous sensory retinal detachment with subretinal serofibrinous exudate followed by subretinal fibrosis and fibrotic scar formation with contracting bands. After tapering of the corticosteroid dosage to a low level the retinal detachment resolved without laser treatment.
Conclusion: The finding suggests that during systemic corticosteroid treatment atypical manifestations of CSCR may develop with subretinal fibrosis and scar formation.
Similar articles
-
Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.Ophthalmology. 1995 May;102(5):737-47. doi: 10.1016/s0161-6420(95)30960-8. Ophthalmology. 1995. PMID: 7777273
-
Central serous chorioretinopathy complicating systemic corticosteroid therapy.Eur J Ophthalmol. 1997 Jul-Sep;7(3):297-300. doi: 10.1177/112067219700700317. Eur J Ophthalmol. 1997. PMID: 9352287
-
Subretinal fibrosis in central serous chorioretinopathy.Ophthalmology. 1995 Jul;102(7):1077-88. doi: 10.1016/s0161-6420(95)30908-6. Ophthalmology. 1995. PMID: 9121756
-
Central serous chorioretinopathy in patients with systemic lupus erythematosus.Ophthalmology. 1996 Dec;103(12):2081-90. doi: 10.1016/s0161-6420(96)30385-0. Ophthalmology. 1996. PMID: 9003342 Review.
-
Bullous variant of idiopathic central serous chorioretinopathy.Br J Ophthalmol. 2000 May;84(5):485-92. doi: 10.1136/bjo.84.5.485. Br J Ophthalmol. 2000. PMID: 10781512 Free PMC article. Review.
Cited by
-
Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1429-1439. doi: 10.1007/s00417-018-4015-8. Epub 2018 Jun 4. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 29869216 Free PMC article.
-
Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.Korean J Ophthalmol. 2015 Dec;29(6):389-95. doi: 10.3341/kjo.2015.29.6.389. Epub 2015 Nov 25. Korean J Ophthalmol. 2015. PMID: 26635455 Free PMC article.
-
Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy.Turk J Ophthalmol. 2022 Apr 28;52(2):147-152. doi: 10.4274/tjo.galenos.2022.93213. Turk J Ophthalmol. 2022. PMID: 35481737 Free PMC article.
-
Severe bilateral central serous chorioretinopathy in a black patient: 16 years follow-up.Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):460-3. doi: 10.1007/s00417-006-0342-2. Epub 2006 May 12. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 16691424
-
Retinal and choroidal changes in steroid-associated central serous chorioretinopathy.Int J Retina Vitreous. 2018 Apr 2;4:11. doi: 10.1186/s40942-018-0115-1. eCollection 2018. Int J Retina Vitreous. 2018. PMID: 29619248 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical